PAPER Saint-Aubert L, Sagot C, Wallon D, Hannequin D, Payoux P, Nemmi F, Bezy C, Chauveau N, Campion D, Puel M, Chollet F, Pariente J
SEARCH RESULTS
331398 RESULTS
PAPER Oosterveld SM, Kessels RP, Hamel R, Ramakers IH, Aalten P, Verhey FR, Sistermans N, Smits LL, Pijnenburg YA, van der Flier WM, Olde Rikkert MG, Melis RJ
The influence of co-morbidity and frailty on the clinical manifestation of patients with Alzheimer's disease.
J Alzheimers Dis. 2014;42(2):501-9. PubMed: 24898646PAPER Graf CE, Rossi C, Giannelli SV, Nobari BH, Gold G, Herrmann FR, Zekry D
Vitamin D is not associated with cognitive status in a cohort of very old hospitalized patients.
J Alzheimers Dis. 2014;42 Suppl 3:S53-61. PubMed: 24898645PAPER Bueche CZ, Garz C, Stanaszek L, Niklass S, Kropf S, Bittner D, Härtig W, Reymann KG, Heinze HJ, Carare RO, Schreiber S
Impact of N-Acetylcysteine on cerebral amyloid-β plaques and kidney damage in spontaneously hypertensive stroke-prone rats.
J Alzheimers Dis. 2014;42 Suppl 3:S305-13. PubMed: 24898644PAPER Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E
The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
J Alzheimers Dis. 2014;42 Suppl 3:S281-8. PubMed: 24898643PAPER Macdonald IR, Rockwood K, Martin E, Darvesh S
Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
J Alzheimers Dis. 2014;42(2):379-84. PubMed: 24898642PAPER Pavlovic AM, Pekmezovic T, Tomic G, Trajkovic JZ, Sternic N
Baseline predictors of cognitive decline in patients with cerebral small vessel disease.
J Alzheimers Dis. 2014;42 Suppl 3:S37-43. PubMed: 24898641PAPER Eichler T, Thyrian JR, Hertel J, Köhler L, Wucherer D, Dreier A, Michalowsky B, Teipel S, Hoffmann W
Rates of formal diagnosis in people screened positive for dementia in primary care: results of the DelpHi-Trial.
J Alzheimers Dis. 2014;42(2):451-8. PubMed: 24898640PAPER Kim E, Jung YS, Kim H, Kim JS, Park M, Jeong J, Lee SK, Yoon HG, Hwang GS, Namkoong K
Metabolomic signatures in peripheral blood associated with Alzheimer's disease amyloid-β-induced neuroinflammation.
J Alzheimers Dis. 2014;42(2):421-33. PubMed: 24898638PAPER Olazarán J, González B, Osa-Ruiz E, Felipe-Ruiz S, Boyano I, Fontani V, Castagna A, Mendoza C, Zea MA, Frades B, Rinaldi S, Martínez-Martín P
Motor effects of radio electric asymmetric conveyer in Alzheimer's disease: results from a cross-over trial.
J Alzheimers Dis. 2014;42(1):325-32. PubMed: 24898637PAPER Moon M, Choi JG, Kim SY, Oh MS
Bombycis excrementum reduces amyloid-β oligomer-induced memory impairments, neurodegeneration, and neuroinflammation in mice.
J Alzheimers Dis. 2014;41(2):599-613. PubMed: 24898636PAPER Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
J Alzheimers Dis. 2014;42(1):291-300. PubMed: 24898635PAPER Barbisin M, Vanni S, Schmädicke AC, Montag J, Motzkus D, Opitz L, Salinas-Riester G, Legname G
Gene expression profiling of brains from bovine spongiform encephalopathy (BSE)-infected cynomolgus macaques.
BMC Genomics. 2014 Jun 5;15:434. PubMed: 24898206PAPER Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN
Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images.
J Nucl Med. 2014 Jun 4;55(8):1305-1307. PubMed: 24898026PAPER Rosse G
Dihydrooxazines As Inhibitors of BACE-1 or BACE-2.
ACS Med Chem Lett. 2013 May 9;4(5):433-4. Epub 2013 Mar 19 PubMed: 24900690Current Filters
No filters selected